rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gabrielle Sulzberger

Director

Company insider

Files Form 4 as: Director, Eli Lilly and; Director, Mastercard; Director, Cerevel Therapeutics Holdings; Director, Warby Parker; Director, Brixmor Property Group; Director, Whole Foods Market; Director, Stage Stores; Director, Bright Horizons Family Solutions.

Every Form 4 they filed

In numbers

Trades disclosed
195
Buys
7
Sells
12
Bought
$429K
Sold
$3.5M
Companies
9
Companies where not an officer
9
First trade
9 May 2006
Last trade
19 Oct 2026
Last filed
20 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LLY Eli Lilly andDirector · Pharmaceuticals · last 19 Oct 20261 buy · 0 sells
MA MastercardDirector · Payments & Processors · last 16 Jun 20260 buys · 0 sells
Cerevel Therapeutics HoldingsDirector · last 1 Aug 20241 buy · 0 sells
WRBY Warby ParkerDirector · Medical Devices · last 7 Jun 20240 buys · 1 sell
BRX Brixmor Property GroupDirector · REITs · last 1 Jun 20212 buys · 0 sells
Whole Foods MarketDirector · last 28 Aug 20172 buys · 11 sells
Stage StoresDirector · last 10 Jun 20140 buys · 0 sells
Bright Horizons Family SolutionsDirector · last 28 May 20080 buys · 0 sells
Indymac BancorpOther · last 19 Mar 20081 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
19 Oct 2026filed 20 Oct 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9583.998 at $1,240.34filing
21 Sep 2026filed 22 Sep 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9584.257 at $1,164.89filing
21 Sep 2026filed 22 Sep 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9624.26 at $1,164.89filing
17 Aug 2026filed 18 Aug 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9584.191 at $1,183.16filing
17 Aug 2026filed 18 Aug 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9574.19 at $1,183.16filing
20 Jul 2026filed 21 Jul 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9584.323 at $1,146.90filing
20 Jul 2026filed 21 Jul 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9554.32 at $1,146.90filing
16 Jun 2026filed 18 Jun 2026MA MastercardPayments & ProcessorsSEC FORM 4 Code A—509 at $0.00filing
16 Jun 2026filed 18 Jun 2026MA MastercardPayments & ProcessorsSEC FORM 4 Code A—509 at $0.00filing
15 Jun 2026filed 16 Jun 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9584.39 at $1,129.35filing
15 Jun 2026filed 16 Jun 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9584.39 at $1,129.35filing
18 May 2026filed 19 May 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9585.018 at $988.09filing
18 May 2026filed 19 May 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9605.02 at $988.09filing
20 Apr 2026filed 21 Apr 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9585.39 at $919.90filing
20 Apr 2026filed 21 Apr 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9585.39 at $919.90filing
16 Mar 2026filed 17 Mar 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9585.013 at $989.12filing
16 Mar 2026filed 17 Mar 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9555.01 at $989.12filing
17 Feb 2026filed 18 Feb 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9594.786 at $1,036.05filing
17 Feb 2026filed 18 Feb 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9634.79 at $1,036.05filing
20 Jan 2026filed 21 Jan 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4,9594.762 at $1,041.29filing

Sectors

Health Care2
Real Estate2
Not placed15

Buys in green, sells in red, by the company’s sector.

Related people

Ralph AlvarezDirector · Director at ELI LILLY & Co, filing Form 4 there in the last year
J. Erik FyrwaldDirector · Director at ELI LILLY & Co, filing Form 4 there in the last year
Juan R. LucianoDirector · Director at ELI LILLY & Co, filing Form 4 there in the last year
Hai LingChief Financial Officer · Chief Financial Officer at Mastercard, filing Form 4 there in the last year
Julius GenachowskiDirector · Director at Mastercard, filing Form 4 there in the last year
Jeffrey Jacob RaiderDirector · Also traded WRBY in the last 90 days
Neil Harris BlumenthalCo-Chief Executive Officer · Also traded WRBY in the last 90 days
Donald J. TrumpPresident · Also traded WRBY in the last 90 days